Denmark’s C25 index opened in the red on Tuesday following the Easter holiday. Just a quarter of an hour after the market ...

Amid a grim day on the stock market, consumer confidence shows that Danes are pessimistic about the future.According to ...

After some tough weeks, the Danish stock market opened poorly following the Easter holidays. The C25 index fell by 1.7% in ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...

The scale of President Donald Trump’s tariffs has exceeded even the most bearish forecasts — and could impact these five ...

The Startup Policy Forum (SPF)—which represents over 50 tech firms—said it has urged the Indian government to create a ...

Novo Nordisk A/S has moved -53.6% over the last year, and the S&P 500 logged a change of 5.4% NVO has an average analyst ...

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

The global pharmaceutical industry could generate about $1.2 trillion in sales in 2025, according to Statista, and projections call for 4.7% annual growth through 2029. The cancer treatment segment ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...